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The molecule of the title compound, C8H3Cl2FN2,i s
essentially planar, with a maximum deviation of 0.018 (2) A ˚ .
In the crystal,  –  stacking is observed between parallel
quinazoline moieties of adjacent molecules, the centroid–
centroid distance being 3.8476 (14) A ˚ .
Related literature
For the synthesis of quinazoline derivatives, see: Roberts et al.
(2011); Gao et al. (2010); Li et al. (2009); Connolly et al. (2005).
For the pharmacological properties of quinazoline analogues,
see: Koller et al. (2011); Garofalo et al. (2011); Yang et al.
(2011). For related structures, see: Jia et al. (2011); Ouahrouch
et al. (2011).
Experimental
Crystal data
C8H3Cl2FN2
Mr = 217.02
Monoclinic, P21=n
a = 3.8257 (3) A ˚
b = 15.0664 (9) A ˚
c = 14.3453 (6) A ˚
  = 95.102 (5)
V = 823.59 (9) A ˚ 3
Z =4
Mo K  radiation
  = 0.75 mm
1
T = 293 K
0.35  0.30  0.25 mm
Data collection
Agilent Xcalibur Eos diffractometer
Absorption correction: multi-scan
(CrysAlis PRO; Agilent, 2010)
Tmin = 0.780, Tmax = 0.835
3156 measured reﬂections
1452 independent reﬂections
1120 reﬂections with I >2  (I)
Rint = 0.025
Reﬁnement
R[F
2 >2  (F
2)] = 0.038
wR(F
2) = 0.095
S = 1.07
1452 reﬂections
118 parameters
H-atom parameters constrained
 max = 0.20 e A ˚ 3
 min = 0.23 e A ˚ 3
Data collection: CrysAlis PRO (Agilent, 2010); cell reﬁnement:
CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to
solve structure: SHELXTL (Sheldrick, 2008); program(s) used to
reﬁne structure: SHELXTL; molecular graphics: SHELXTL; soft-
ware used to prepare material for publication: SHELXTL.
This project was supported by the NSFC (grant No.
81001383) and the Doctoral Foundation of the Ministry of
Education, China (grant No. 20105103120009).
Supplementary data and ﬁgures for this paper are available from the
IUCr electronic archives (Reference: XU5446).
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2,4-Dichloro-7-fluoroquinazoline
Feng Gao, Yun-Fei Hu and Jin-Long Wang
Comment 
As the important six-membered heterocycles, quinazoline derivatives have always drawn the attention of organic and 
medicinal chemists for their various biological activities and significant synthetic materials. Several quinazoline-
containing compounds have been approved by FDA, such as EGFR inhibitors Iressa and Tarceva used in the treatment of 
cancer, as well as alpha adrenergic receptor antagonists Praosin and Alfuzosine, which have been used for anti-
hypertensive drugs in clinic. In addition, quinazoline derivatives also have been reported as anti-inflammatory, 
antibacterial or anticonvulsant agents. Most recently, quinazoline analogues have been found as selective VEGFR-2 
receptor tyrosine kinase inhibitors, novel heat shock protein 90 inhibitors, EGFR Tyrosine kinase inhibitors, as well as 
glucocerebrosidase inhibitors.
Experimental 
2,4-Dichloro-7-fluoroquinazoline was synthesized presently through two steps reactions implying 2-amino-4-fluoro-
benzoic acid as the starting material: 1. Acetic acid (80 ml) was added to a suspension of 2-amino-4-fluorobenzoic acid 
(100 g, 0.645 mol) in water (2L), a solution of NaOCN (105 g, 1.616 mol) in water (800 ml) was added dropwise under 
vigorous stirring with a mechanical stirrer. The reaction mixture was stirred at room temperature for 30 min, and NaOH 
(480 g, 12 mol) was added in small portions, and the mixture was cooled to room temperature. Then concentrated HCl 
(~1.2L) was added dropwise to the reaction mixture to attain pH ~4 (strong foaming!). The formed precipitate was 
separated by filtration, washed with water, and air-dried to give compound 7-fluoroquinazoline-2,4(1H,3H)-dione (yield 
82%, 95 g). It was used in the next step without any purification. 2. A mixture of compound 7-fluoro-
quinazoline-2,4(1H,3H)-dione (150 g, 0.83 mol), N,N-diethylaniline (125 g, 0.84 mol), and POCl3 (500 ml) was refluxed 
for overnight. Most of POCl3 was removed by rotary vapor. The residue was poured into the mixture water/ice (~4L), and 
the formed precipitate was separated by filtration, washed with water, and vacuum-dried to give compound 2,4-di-
chloro-7-fluoroquinazoline (yield 94%, 170 g). Single crystals of 2,4-dichloro-7-fluoroquinazoline, C8H3Cl2FN2, were 
recrystallized from acetone, mounted in inert oil and transferred to the cold gas stream of the diffractometer.
Refinement 
H atoms were placed in calculated positions and treated as riding atoms [C—H = 0.93–0.96 Å], with Uiso(H) = 1.5Ueq(C) 
for methyl H atoms and 1.2Ueq(C) for others.
Computing details 
Data collection: CrysAlis PRO (Agilent, 2010); cell refinement: CrysAlis PRO (Agilent, 2010); data reduction: CrysAlis 
PRO (Agilent, 2010); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine 
structure: SHELXTL (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare 
material for publication: SHELXTL (Sheldrick, 2008).supplementary materials
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Figure 1
Molecular structure of showing 30% probability displacement ellipsoids. 
Figure 2
The packing viewed along c axis with π···π interactions, indicating the dimer. 
2,4-Dichloro-7-fluoroquinazoline 
Crystal data 
C8H3Cl2FN2
Mr = 217.02
Monoclinic, P21/n
a = 3.8257 (3) Å
b = 15.0664 (9) Å
c = 14.3453 (6) Å
β = 95.102 (5)°
V = 823.59 (9) Å3
Z = 4
F(000) = 432supplementary materials
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Dx = 1.750 Mg m−3
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 1033 reflections
θ = 3.0–25.0°
µ = 0.75 mm−1
T = 293 K
Block, brown
0.35 × 0.30 × 0.25 mm
Data collection 
Agilent Xcalibur Eos 
diffractometer
Radiation source: Enhance (Mo) X-ray Source
Graphite monochromator
Detector resolution: 10.0 pixels mm-1
ω scans
Absorption correction: multi-scan 
(CrysAlis PRO; Agilent, 2010)
Tmin = 0.780, Tmax = 0.835
3156 measured reflections
1452 independent reflections
1120 reflections with I > 2σ(I)
Rint = 0.025
θmax = 25.0°, θmin = 3.1°
h = −4→4
k = −15→17
l = −16→16
Refinement 
Refinement on F2
Least-squares matrix: full
R[F2 > 2σ(F2)] = 0.038
wR(F2) = 0.095
S = 1.07
1452 reflections
118 parameters
0 restraints
Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map
Hydrogen site location: inferred from 
neighbouring sites
H-atom parameters constrained
w = 1/[σ2(Fo
2) + (0.0389P)2] 
where P = (Fo
2 + 2Fc
2)/3
(Δ/σ)max < 0.001
Δρmax = 0.20 e Å−3
Δρmin = −0.23 e Å−3
Special details 
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and 
torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used 
only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 
are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
xyzU iso*/Ueq
Cl1 0.18763 (19) 0.24582 (4) 0.86579 (4) 0.0500 (3)
Cl2 0.2734 (2) 0.09054 (5) 0.54819 (5) 0.0628 (3)
F1 0.8584 (4) 0.55046 (10) 0.60324 (11) 0.0652 (5)
N1 0.2491 (5) 0.17987 (14) 0.70176 (14) 0.0416 (5)
N2 0.4812 (5) 0.25290 (13) 0.57255 (14) 0.0389 (5)
C1 0.3448 (6) 0.18701 (17) 0.61375 (17) 0.0392 (6)
C2 0.3050 (6) 0.25134 (16) 0.75263 (17) 0.0360 (6)
C3 0.4494 (6) 0.33043 (16) 0.72000 (16) 0.0331 (6)
C4 0.5323 (6) 0.32793 (16) 0.62626 (16) 0.0327 (6)
C5 0.6758 (7) 0.40354 (16) 0.58670 (16) 0.0389 (6)
H5 0.7365 0.4030 0.5253 0.047*
C6 0.7228 (7) 0.47677 (17) 0.64004 (19) 0.0428 (7)supplementary materials
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C7 0.6403 (7) 0.48233 (17) 0.73259 (19) 0.0455 (7)
H7 0.6783 0.5346 0.7665 0.055*
C8 0.5030 (7) 0.40973 (16) 0.77230 (17) 0.0426 (7)
H8 0.4443 0.4122 0.8338 0.051*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
Cl1 0.0595 (5) 0.0612 (5) 0.0313 (4) 0.0047 (4) 0.0158 (3) 0.0092 (3)
Cl2 0.0870 (6) 0.0476 (5) 0.0541 (5) −0.0111 (4) 0.0086 (4) −0.0150 (4)
F1 0.0783 (13) 0.0466 (10) 0.0717 (12) −0.0159 (9) 0.0123 (10) 0.0132 (9)
N1 0.0454 (14) 0.0428 (13) 0.0367 (12) −0.0035 (11) 0.0043 (10) 0.0014 (11)
N2 0.0455 (13) 0.0404 (13) 0.0314 (11) −0.0004 (11) 0.0074 (10) −0.0032 (10)
C1 0.0433 (16) 0.0373 (15) 0.0369 (14) 0.0015 (13) 0.0029 (12) −0.0033 (12)
C2 0.0330 (14) 0.0469 (16) 0.0285 (12) 0.0071 (12) 0.0045 (11) 0.0052 (12)
C3 0.0320 (14) 0.0385 (14) 0.0286 (12) 0.0057 (12) 0.0022 (11) 0.0039 (11)
C4 0.0301 (14) 0.0365 (14) 0.0315 (13) 0.0033 (12) 0.0019 (11) 0.0037 (11)
C5 0.0427 (16) 0.0437 (16) 0.0311 (13) 0.0022 (13) 0.0074 (12) 0.0037 (12)
C6 0.0389 (15) 0.0397 (16) 0.0493 (16) −0.0033 (13) 0.0008 (13) 0.0123 (14)
C7 0.0504 (17) 0.0370 (15) 0.0485 (16) 0.0004 (13) 0.0013 (13) −0.0069 (13)
C8 0.0469 (17) 0.0478 (16) 0.0336 (14) 0.0060 (14) 0.0066 (12) −0.0037 (13)
Geometric parameters (Å, º) 
Cl1—C2 1.724 (2) C3—C8 1.416 (3)
Cl2—C1 1.739 (3) C4—C5 1.406 (3)
F1—C6 1.352 (3) C5—C6 1.346 (3)
N1—C2 1.308 (3) C5—H5 0.9300
N1—C1 1.350 (3) C6—C7 1.394 (4)
N2—C1 1.289 (3) C7—C8 1.360 (3)
N2—C4 1.372 (3) C7—H7 0.9300
C2—C3 1.411 (3) C8—H8 0.9300
C3—C4 1.409 (3)
C2—N1—C1 114.3 (2) C5—C4—C3 119.5 (2)
C1—N2—C4 114.9 (2) C6—C5—C4 118.2 (2)
N2—C1—N1 130.1 (2) C6—C5—H5 120.9
N2—C1—Cl2 116.50 (18) C4—C5—H5 120.9
N1—C1—Cl2 113.36 (19) C5—C6—F1 119.2 (2)
N1—C2—C3 124.0 (2) C5—C6—C7 124.1 (2)
N1—C2—Cl1 116.25 (18) F1—C6—C7 116.7 (2)
C3—C2—Cl1 119.70 (18) C8—C7—C6 118.6 (2)
C4—C3—C2 115.0 (2) C8—C7—H7 120.7
C4—C3—C8 119.6 (2) C6—C7—H7 120.7
C2—C3—C8 125.4 (2) C7—C8—C3 120.0 (2)
N2—C4—C5 118.8 (2) C7—C8—H8 120.0
N2—C4—C3 121.7 (2) C3—C8—H8 120.0